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CLINICAL PRESENTATION
An 18- year- old right- handed male roofer attended the 
emergency department with a short history of progressive 
sensory disturbance, distal limb weakness and gait dysfunc-
tion. He complained of pins and needles starting in his 
fingers and toes and spreading proximally over a two- week 
period in which he developed associated numbness, distal 
weakness and difficulty with his balance. He did not have 
bowel or bladder involvement.
His past medical history was unremarkable; vaccination 
history was complete; he was a non- smoker who took no 
regular medication and denied recent foreign travel or 
illness. He reported an alcohol intake of 20–30 units per 
week and habitual N2O inhalation from ‘whippits’ (whipped 
cream dispenser canisters). Two weeks prior to admission 
he reported inhaling over 30 whippets at a social event with 
symptom onset several days later.
Neurological examination was remarkable for bilateral 
distal vibration and proprioceptive sensory loss more 
pronounced in the lower limbs, mild distal limb weakness 
and pronounced sensory ataxia. The patella deep tendon 
reflexes were preserved but the ankle reflexes were absent. 
He had bilateral flexor plantar responses. There were no 
cerebellar signs, no cranial nerve abnormalities and cogni-
tive function was normal.
DIFFERENTIAL DIAGNOSIS
Nutritional causes of myeloneuropathy were considered 
including serum copper, folic acid and vitamin E deficien-
cies, although vitamin B12 deficiency was suspected early 
due the history of N2O use. Guillain- Barré Syndrome was 
also favoured initially due to the prominent ascending 
peripheral neuropathy despite the lack of antecedent 
illness. Other aetiologies including metabolic, toxic, infec-
tive, inflammatory (transverse myelitis) and paraneoplastic 
disorders were also considered.
INVESTIGATIONS/IMAGING FINDINGS
Unenhanced MRI of the cervical spine demonstrated bilat-
eral symmetric high T2 signal within the dorsal columns 
extending from the level of C2 to T2 (Figure  1), with 
minimal cord expansion. Bilateral high T2 signal within 
the posterior funiculus gave rise to the inverted ‘V’ sign,1 
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SUMMARY
Nitrous oxide (N2O) has several traditional uses as a surgical and dental anaesthetic, as well as in aerosol spray propel-
lants. It is the combination of analgesic and euphoric qualities coupled with accessibility as an over- the- counter house-
hold item that lends N2O to recreational use. Despite increasing evidence that prolonged use of N2O both medically and 
as a drug of abuse can cause disabling neurological side- effects, it remains widely used.
We present the case of an 18- year- old male who was diagnosed with subacute combined degeneration of the cord 
(SCDC) secondary to acute, heavy recreational use of N2O. The patient presented with progressive paraesthesia 
affecting his hands and feet associated with distal weakness. MRI of the cervical spine revealed symmetric bilateral high 
T2 signal within the dorsal columns extending from the level of C2 to T2 with the inverted ‘V’ sign on axial T2- weighted 
slices indicative of SCDC. Although vitamin B12 levels were within normal range, marked elevation of methylmalonic 
acid and homocysteine support the diagnosis of B12 inactivation and functional B12 deficiency, which fully resolved 
with treatment.
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normal appearances of the parenchyma, ventricles and cerebro-
spinal fluid spaces.
Further workup revealed that vitamin B12 was within normal 
range at 171 pg ml−1; (145–569 pg ml−1). Methylmalonic acid was 
markedly elevated at 3.60 h µmol/L (0.10–0.42 µmol/L) as was 
homocysteine at 67.7 µmol/L (2.0–14.3 µmol/L) supporting the 
diagnosis of functional B12 deficiency. Full blood count, thyroid 
function, folate, copper and vitamin E levels were all normal. 
Antiganglioside, aquaporin four and MOG antibodies were 
negative. Cerebrospinal fluid analysis was entirely normal.
The combination of myelopathy, peripheral neuropathy, elevated 
methylmalonic acid and elevated homocysteine with typical MRI 
changes were overwhelmingly suggestive of SCDC secondary to 
functional B12 deficiency.
TREATMENT
On the second day of admission, the patient commenced 1000 
mcg intramuscular hydroxocobalamin injections on alternative 
days for 2 weeks, followed by 1000 mcg every 2 months for a 
year. He was discharged after 3 days of admission at which time 
his weakness had improved but sensory disturbance persisted.
OUTCOME AND FOLLOW-UP
Outpatient nerve conduction (NCS) and electromyography 
(EMG) studies were performed following discharge. NCS showed 
a length- dependent, predominantly motor axonal neuropathy 
in the lower limbs with some slowing of sensory conduction 
velocities. The EMG revealed corresponding acute denervation 
changes in the distal leg musculature. These findings are consis-
tent with the peripheral neuropathy seen in vitamin B12 defi-
ciency. The clinical team did not feel that a follow- up MRI was 
indicated because it would not have changed management. Six 
months following his admission symptoms had fully resolved 
and he had made a complete recovery.
DISCUSSION
N2O has several traditional uses as a surgical and dental anaes-
thetic, as well as in aerosol spray propellants. It is this combina-
tion of analgesic and euphoric qualities coupled with accessibility 
as an over the- counter household item that lends N2O to recre-
ational use. Despite increasing evidence that prolonged use of 
N2O both medically and as a drug of abuse can cause disabling 
neurological side- effects, it remains widely used.2,3
Since the first Global Drugs Survey in 2014, recreational N2O 
use in the UK has risen from 20 to 31%.3 This is reflected in the 
increasing number of case reports documenting vitamin B12 
deficiency secondary to recreational misuse causing SCDC. 
A 2018 case series has emphasised the public health impact of 
recreational N2O use, postulating that many users are unaware 
of the harmful effect of a drug that was legal to consume prior to 
May 2016.4 Keddie and colleagues suggest future efforts focus on 
ascertaining the true extent of the problem, identifying at- risk 
groups and raising public awareness to limit long- term neuro-
logical sequelae.
Figure 1. Sagittal T2 MRI cervical spine. There is high signal 
discretely involving the posterior column tracts with minimal 
cord expansion.
Figure 2. Axial T2 MRI cervical spine. Arrow: bilateral high- 
intensity T2 signal within the posterior funiculus, resembling 
the appearance of an inverted letter ‘V’.
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SCDC is a neurodegenerative demyelinating disorder secondary 
to vitamin B12 deficiency. The condition is typically seen in the 
context of primary malnutrition, pernicious anaemia, the use of 
proton pump inhibitors and conditions affecting the terminal 
ileum such as Crohn’s disease, coeliac disease and surgical 
resection.5
Active vitamin B12 is essential for several enzyme- catalysed reac-
tions, most notably in the synthesis of myelin.6 Active vitamin 
B12 comprises of methylcobalamin and adenosylcobalamin 
coenzymes, methylcobalamin is a cofactor in the synthesis of 
methionine and adenosylcobalamin is a cofactor in the synthesis 
of succinyl Cofactor A (CoA). Methylcobalamin methylates 
homocysteine by acting as a cofactor for the enzyme methionine 
synthase. Methionine synthase is a precursor to methionine 
and ultimately S- adenosylmethionine6 (Figure  3). S- adenosyl-
methionine is the major methyl donor required for numerous 
biochemical functions and cellular processes including the 
synthesis of nucleic acids, catecholamines, and myelin sheath 
phospholipids.7
Adenosylcobalamin, the second active form of vitamin B12, 
acts as a cofactor for the enzyme methylmalonyl coenzyme CoA 
mutase which converts methylmalonyl- CoA into succinyl- CoA 
(Figure  3). Vitamin B12 deficiency leads to accumulation of 
methylmalonyl- CoA, high levels of which are used instead of 
malonyl- CoA for fatty acid synthesis. Myelin synthesised with 
abnormal methylmalonyl- CoA fatty acids is unstable and prone 
to degradation, thus causing demyelinating neuropathy.7
N2O inactivates vitamin B12 (cobalamin) by irreversibly 
oxidising the cobalt ion.8 Inactive vitamin B12 equates to a 
functional deficiency of methylcobalamin and adenosylcobal-
amin resulting in elevated levels of both methylmalonic acid 
and homocysteine, as seen in our patient.4 Several articles have 
been published reporting myeloneuropathy in patients exposed 
to N2O in spite of having normal vitamin B12 levels, levels 
may be normal in up to 30% of patients.9,10 If demyelination is 
suspected then is important to look for elevated levels of the B12- 
dependent metabolites, methylmalonic acid and homocysteine, 
despite normal serum vitamin B12 levels.9
Loss of normal myelin around axons in the central nervous 
system manifests as high signal in the white matter on T2- 
weighted MRI.7–10 The lesions are typically non- enhancing and 
begin in the upper thoracic cord. Progression may be ascending 
or descending. Demyelination in SCDC has a predilection 
for the dorsal columns, it unclear why the corticospinal white 
matter tracts are not involved.8 There are rarer reports of ante-
rior column involvement.11 Bilateral high T2 signal within the 
posterior funiculus gives rise to the inverted ‘V’ sign or inverted 
“rabbit ears” appearance on axial imaging.1 Axial T2 images are 
more sensitive at detecting cord lesions as faint signal abnormal-
ities which are subject to partial voluming on sagittal sequences.7 
Figure 3. Vitamin B12 is a cofactor in conversion of methylmalonyl coenzyme A to succinyl coenzyme A and of homocysteine to 
methionine. Elevated levels of the substrates methylmalonic acid and homocysteine can be used to identify vitamin B12 inacti-
vation despite normal serum B12 concentrations. MS = methionine synthase, MCCoAM = methylmalonyl coenzyme CoA mutase.
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Demyelination of the thoracic dorsal columns appears to be the 
earliest manifestation of vitamin B12 deficiency and is considered 
a reversible pathological change in SCDC. Other less frequently 
documented MRI findings include minimal spinal cord enlarge-
ment, dorsal spinal cord hypointensity on T1 weighted imaging, 
T2 hyperintense signal in lateral columns of cord and cerebral 
white matter.1,7 Imaging differentials include infectious and 
post- infectious myelitis, metabolic and nutritional disturbance 
(including copper and vitamin E deficiency), neoplasia and para-
neoplastic myelopathy, radiation myelitis, traumatic cord injury, 
multiple sclerosis and neuromyelitis optica spectrum disorder.
Not all patients will present with typical MRI findings and it is 
notable that investigations are complementary and not exclu-
sive. There are reports of patients with normal cord imaging 
and no clinical evidence of myeloneuropathy who were found 
to have sensorimotor neuropathy with demyelinating features 
on neurophysiology.12 In our case, Guillain- Barré Syndrome was 
suspected before neuroimaging and later biochemical screening 
revealed a functional B12 deficiency. There are reports of patients 
with SCDC going on to receive intravenous immunoglobulin 
therapy due to initial suspicion of Guillain–Barré Syndrome.12
Management of SCDC secondary to B12 inactivation includes 
cessation of N2O inhalation and high- dose intramuscular 
hydroxocobalamin for 12 months as described above.5,13 Not all 
patients achieve full neurological recovery.7–9,12
LEARNING POINTS
• Diagnosing subacute combined degeneration of the cord 
secondary to N2O misuse requires a thorough medical and 
social history, clinical examination demonstrating myelopathy 
and/or peripheral neuropathy and/or MRI findings consistent 
with a typical demyelination pattern.
• Vitamin B12 deficiency cannot be excluded by serum B12 
levels alone and clinical suspicion should prompt testing for 
functional B12 deficiency.
• Functional B12 deficiency is biochemically supported by 
elevated homocysteine and methylmalonic acid and can 
respond favourably to treatment.
• Demyelination classically occurs in the cervical or upper 
thoracic cord. Axial MRI demonstrates high T2 signal within 
the dorsal columns giving rise to the inverted ‘V’ sign. Sagittal 
MRI typically demonstrates dorsal spinal cord high T2 signal.
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